NÖK Therapeutics is at the forefront of developing innovative NK cell-based cancer therapies. Our mission is to harness the power of the body’s natural defenses to combat cancer. Our team comprises leading experts in NK cell research, dedicated to advancing treatments for both hematological malignancies and solid tumors. We are committed to improving patient outcomes through our proprietary technology platform, which enhances the tumor-killing capabilities of NK cells derived from patients’ own blood. NK cells have the unique ability to recognize and destroy cancer cells, providing a targeted approach to cancer therapy.
Company Details
- Address
- 2009 Mackenzie Way,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://noktx.com
- Keywords
- Burgener AG.
- HQ
- Cranberry Township, Pennsylvania
Nök Therapeutics Questions
Nök Therapeutics's website is http://noktx.com
Nök Therapeutics's LinkedIn profile is https://www.linkedin.com/company/n%C3%B6k-therapeutics
Nök Therapeutics's industry is
Biotechnology Research
Nök Therapeutics's top competitors are
Phi Networks Group,
Kycel,
Massachusetts Albanian American Society "besa",
Gear Therapeutics,
Burgener Ag,
Snap Biosciences,
Nok Human Capital,
Gami World,
Bivium Biosciences,
Jabez Biosciences.
Nök Therapeutics's categories are Biotechnology Research
